Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum

Farca, Anna; Miniscalco, B.; Badino, P.; Odore, R.; Monticelli, P.; Trisciuoglio, A.; Ferroglio, E.
June 2012
Parasitology Research;Jun2012, Vol. 110 Issue 6, p2509
Academic Journal
Despite the availability of different therapeutic options, canine visceral leishmaniosis (CVL) remains a challenging disease to treat. Recently miltefosine has been registered for use in dogs, and different studies have demonstrated its leishmanicidal effect. Moreover, it has been suggested that fluoroquinolones, compared to standard chemotherapeutic agents, could be an effective and pragmatic alternative to treat CVL. The efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum was assessed in vitro by incubating increasing concentrations of the drugs with a standard parasite inoculum. Miltefosine was significantly more efficacious than marbofloxacin ( P < 0.05) against the two strains of L. infantum either alone or in combination with allopurinol. Both drugs were significantly ( P < 0.05) more efficacious when associated with allopurinol than alone.


Related Articles

  • Allopurinol Resistance in Leishmania infantum from Dogs with Disease Relapse. Yasur-Landau, Daniel; Jaffe, Charles L.; David, Lior; Baneth, Gad // PLoS Neglected Tropical Diseases;1/6/2016, Vol. 10 Issue 1, p1 

    Background: Visceral leishmaniasis caused by the protozoan Leishmania infantum is a zoonotic, life threatening parasitic disease. Domestic dogs are the main peridomestic reservoir, and allopurinol is the most frequently used drug for the control of infection, alone or in combination with other...

  • Challenges for management of post kala-azar dermal leishmaniasis and future directions. Mondal, Dinesh; Hamano, Shinjiro; Hasnain, Md Golam; Satoskar, Abhay R. // Research & Reports in Tropical Medicine;2014, Vol. 5, p105 

    Post kala-azar dermal leishmaniasis (PKDL) is a skin complication resulting from infection with Leishmania donovani (LD) parasite. It mostly affects individuals who have previously suffered from visceral leishmaniasis (VL) caused by LD. In some cases, PKDL develops among people infected with LD,...

  • Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis. Freitas, Elisangela Oliveira; Nico, Dirlei; Alves-Silva, Marcus Vinícius; Morrot, Alexandre; Clinch, Keith; Evans, Gary B.; Tyler, Peter C.; Schramm, Vern L.; Palatnik-de-Sousa, Clarisa B. // PLoS Neglected Tropical Diseases;12/23/2015, Vol. 9 Issue 12, p1 

    Background: Immucillins ImmA (IA), ImmH (IH) and SerMe-ImmH (SMIH) are synthetic deazapurine nucleoside analogues that inhibit Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis multiplication in vitro without macrophage toxicity. Immucillins are compared to the Glucantime...

  • Application of DsbA Signal Peptide for Soluble Expression of Leishmania infantum P4 Nuclease in E. coli. Rahbarnia, Leila; Farajnia, Safar; Naghili, Behrooz // Asian Journal of Animal & Veterinary Advances;Apr2012, Vol. 7 Issue 4, p326 

    Drugs available for treatment of Visceral Leishmaniasis (VL) are toxic and drug resistance is increasing in many parts of the world, thus it seems that vaccine development is an ideal method for prevention and control of VL. P4 nuclease of L. infantum, an amastigote stage specific protein, is...

  • Major Four-year Project Launched to Treat Kala-Azar.  // India -- West;1/27/2012, Vol. 37 Issue 10, pA30 

    The article reports on the kala-azar, a comprehensive four-year project, launched by an international consortium for diagnosis and treatment of visceral leishmaniasis in India and Bangladesh.

  • Failure of Miltefosine Treatment in Two Dogs with Natural Leishmania infantum Infection. Proverbio, Daniela; Spada, Eva; De Giorgi, Giada Bagnagatti; Perego, Roberta // Case Reports in Veterinary Medicine;2014, p1 

    Two dogs, with naturally acquired canine leishmaniasis, were treated orally with miltefosine (2mg/kg q 24 hr) and allopurinol (10mg/kg q 12 hr) for 28 days. Both dogs showed good initial response to therapy, with reduction in clinical signs and improvement of clinicopathological changes....

  • Evidence that the High Incidence of Treatment Failures in Indian Kala-Azar Is Due to the Emergence of Antimony-Resistant Strains of Leishmania donovani. Lira, Rosalia; Sundar, Shyam; Makharia, A.; Kenney, Richard; Gam, Albert; Saraiva, Elvira; Sacks, David // Journal of Infectious Diseases;8/1/99, Vol. 180 Issue 2 

    Investigates the treatment failures in Kala-Azar infection due to antimony-resistant strains of Leishmania donovani in India. Characterization of kala-azar; Use of splenic aspirates as a source material for the culture of promastigote; Susceptibility of intracellular amastigotes to sodium...

  • Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India. Ramesh, V.; Singh, Ruchi; Avishek, Kumar; Verma, Aditya; Deep, Deepak Kumar; Verma, Sandeep; Salotra, Poonam // PLoS Neglected Tropical Diseases;12/7/2015, Vol. 9 Issue 12, p1 

    A correction to the article "Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India," by V. Ramesh and colleagues is presented.

  • Gold treatment for kala-azar. Singh, M.P.; Mishra, M.; Khan, A.B.; Ramdas, S.L.; Panjiyar, S. // BMJ: British Medical Journal (International Edition);11/25/89, Vol. 299 Issue 6711, p1318 

    Investigates the use of gold treatment for patients with kala-azar. Enlargement of the liver; Occurrence of leishmania; Toxicity of the gold treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics